COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data.
Inmaculada HernandezMeiqi HeJingchuan GuoMina TadrousNico GabrielGretchen SwabeWalid F GelladUtibe R EssienSamir SabaEmelia J BenjaminJared W MagnaniPublished in: PloS one (2023)
In a nationwide cohort of 19.5 million individuals, new diagnoses of AF decreased substantially following the onset of the COVID-19 pandemic. Our findings evidence pandemic disruptions in access to care for AF, which are concerning because delayed diagnosis interferes with timely treatment to prevent complications.
Keyphrases
- atrial fibrillation
- catheter ablation
- oral anticoagulants
- healthcare
- left atrial
- sars cov
- coronavirus disease
- left atrial appendage
- heart failure
- cross sectional
- direct oral anticoagulants
- health insurance
- palliative care
- percutaneous coronary intervention
- risk factors
- pain management
- venous thromboembolism
- coronary artery disease
- affordable care act
- data analysis
- replacement therapy
- deep learning
- chronic pain